MedPath

BIOFACTURA AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
Private
Employees
-
Market Cap
-
Website

Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults

Phase 1
Completed
Conditions
Psoriasis
Interventions
Drug: US-STELARA®
Drug: EU-STELARA®
First Posted Date
2021-04-13
Last Posted Date
2022-03-25
Lead Sponsor
BioFactura Australia Pty Ltd.
Target Recruit Count
216
Registration Number
NCT04843631
Locations
🇦🇺

Nucleus Network, Brisbane, Queensland, Australia

🇳🇿

NZCR, Grafton, Auckland, New Zealand

🇦🇺

CMAX, Adelaide, South Australia, Australia

© Copyright 2025. All Rights Reserved by MedPath